Home
Journals
A-Z Journals
Browse By Subject
Guidelines & Policies
Editorial Policies
Online Submission
Instructions to Authors
Policies
Publication ethics & malpractice statement
Reviewers
Terms and Conditions
Advertising
Conferences
Contact us
Language
Spanish
Chinese
Russian
German
French
Japanese
Portuguese
Hindi
Telugu
Tamil
Journal of Leukemia
Open Access
ISSN: 2329-6917
+44 1300 500008
Journal Home
Editorial Panel
Editor-in-Chief
Editorial Board
Instructions for Authors
Instructions for Authors
Publication ethics & malpractice statement
Submit Manuscript
Aims and Scope
Articles in process
Archive
Special Issues
Guidelines
Upcoming Special Issues
Contact
Tom Borge Johannesen
Tom Borge Johannesen
Cancer Registry of Norway, Oslo, Norway.
Biography
Tom Borge Johannesen is a well-known researcher working in Cancer Registry of Norway, Oslo, Norway and has extended valuable service for many years and has been a recipient of many awards and grants.
Relevant Topics
Acute Lymphoblastic Leukemia
Acute Megakaryocytic Leukemia
Acute Myelomonocytic Leukemia
Acute Myleoid Leukemia
Adaptive Cell Therapy
Advanced Cell Therapy
Aleukemic Leukemia
Anti-Cancer Drugs
Anti-tumor Antibiotics
Antimetabolites
Antineoplastic Agents
Autologous Cell
Avastin
Bladder Carcinoma in Situ
Bone Marrow Stem Cell Transplant
Cancer Immunoediting
Cancer Immunology
Cancer Immunotherapies
Cancer Radioimmunotherapy
Cancer Screening
Carcinogens
Cell
Cell Biology
Cell Replacemnt Therapy
Cell Therapy Bioprocessing
Cell Therapy Products
Cellular Immunotherapy
Chemo Side Effects
Chemotherapies
Chemotherapy
Chemotherupatic Agents
Chronic Lymphocytic Leukemia
Chronic Myleloid Leukemia
Cytotoxic Drugs
Dendritic Cell Therapy
Feline Leukemia Complex
Fluorouracil (5-FU)
Hair Follicle Cells
Hairy Cell Leukemia
Hormonal Drugs for Cancer Therapy
Immune Cell Therapy
Immune Suppression
Immunogene response
Immunosurveillance
Immunotherapeutic agents
Immunotherapy or biologic therapy
Leukemia
Leukemia Drugs
Live Cell Therapy
Lymphoma Cancer
Lymphoma Symptoms
Lymphosarcoma
Mast Cell Leukemia
Mesenchymal Cells
Metastasis
Methotrexate
Mitotic Inhibitors
Necrosis
Nucleic Acid Research
Ovation cell therapy
Pediatric Leukemia
Pharmacology of Cancer Drugs
Pharmocology of Cancer Drugs
Plasma Cell Leukemia
Purine Antagoinsts for Cancer Treatment
Radiation Therapy
Recombinant Cytokines
Skin Cell Therapy
Somatic Cell Therapy
Spleen Cancer
Systems of Immune
Targeted Therapy
Topoisomerase Inhibitors
Transitional cell carcinoma (TCC)
Tumor Immunity
Tumour Immunity
Tumour Immunology
Vinblastine
Top